Yoga therapy on elderly patients with fear of fall: an open-label randomised controlled trial (YOFEAR trial)

被引:0
|
作者
Kashyap, Kritartha [1 ]
Dhar, Minakshi [1 ,2 ]
Bisht, Khushboo [3 ]
Bahurupi, Yogesh [4 ]
Pathania, Monika [1 ]
机构
[1] All India Inst Med Sci, Geriatr Med, Rishikesh, Uttarakhand, India
[2] All India Inst Med Sci, Internal Med, Rishikesh, Uttarakhand, India
[3] All India Inst Med Sci, Clin Pharmacol, Rishikesh, Uttarakhand, India
[4] All India Inst Med Sci, Community & Family Med, Rishikesh, Uttarakhand, India
来源
BMJ OPEN | 2023年 / 13卷 / 12期
关键词
GERIATRIC MEDICINE; Health & safety; Quality in health care; Aging; REHABILITATION MEDICINE; OLDER-PEOPLE; BALANCE; GAIT; COMMUNITY; EFFICACY; ADULTS; VALIDATION; EXERCISES;
D O I
10.1136/bmjopen-2022-070540
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Fear of fall is experienced by the elderly irrespective of the presence or absence of history of fall. Falls contribute to injuries that culminate in hospitalisation that incur unwarranted medical expenses. Yoga is unique to Indian cultural practices, with a potential to enhance proprioception. It increases self-body awareness, ultimately improving the balancing capacity of older adults. Thus, the objective of this study is to compare the effect of yoga therapy in the study and control groups at 12 weeks from the baseline.Methods and analysis This study is designed as an open-label, randomised controlled trial (1:1) with a sample size of 62 elderly patients more than or equal to 60 years of age. Participation of either sex, male or female with a fear of fall will be considered. Two randomised groups of 31 participants each will receive standard therapy for their primary diseases as per the local, national or international guidelines. However, participants in the intervention arm will receive additional structured yoga therapy sessions. The primary objective of this study is to assess and compare the change in fear of fall score of participants in each group using Falls Efficacy Scale (FES) and Berg Balance Scale (BBS) at 12 weeks versus baseline. The secondary endpoint will assess the change in the quality of life of participants at 3 months compared with the baseline. Data will be gathered, entered into Microsoft Excel and further analysed by R software (V.4.3.0). Changes in FES-Intervention and BBS of two groups will be compared either by Student's t-test for parametric data or Mann-Whitney U test for non-parametric data. Statistical significance will be considered if p<0.05 at 95% confidence level.Methods and analysis This study is designed as an open-label, randomised controlled trial (1:1) with a sample size of 62 elderly patients more than or equal to 60 years of age. Participation of either sex, male or female with a fear of fall will be considered. Two randomised groups of 31 participants each will receive standard therapy for their primary diseases as per the local, national or international guidelines. However, participants in the intervention arm will receive additional structured yoga therapy sessions. The primary objective of this study is to assess and compare the change in fear of fall score of participants in each group using Falls Efficacy Scale (FES) and Berg Balance Scale (BBS) at 12 weeks versus baseline. The secondary endpoint will assess the change in the quality of life of participants at 3 months compared with the baseline.Data will be gathered, entered into Microsoft Excel and further analysed by R software (V.4.3.0). Changes in FES-Intervention and BBS of two groups will be compared either by Student's t-test for parametric data or Mann-Whitney U test for non-parametric data. Statistical significance will be considered if p<0.05 at 95% confidence level.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Yoga as an Add-on Therapy in Parkinson's Disease: A Single Group Open-label Trial
    Mailankody, Pooja
    Kamble, Nitish
    Bhattacharya, Amitabh
    Bhat, G. S. Shubha
    Arumugam, Thamodharan
    Thennarasu, K.
    Arasappa, Rashmi
    Varambally, Shivarama
    Yadav, Ravi
    Pal, Pramod Kumar
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [22] Preventing pressure ulcers with the Australian Medical Sheepskin: an open-label randomised controlled trial
    Jolley, DJ
    Wright, R
    McGowan, S
    Hickey, MB
    Campbell, DA
    Sinclair, RD
    Montgomery, KC
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (07) : 324 - 327
  • [23] Treatment for Resistant Hypertension Under the Guidance of Pharmacogenomics: A Randomised Controlled Open-Label Trial
    Wang, Ai
    Mbikyo, Muisha Bienvenue
    Zhang, Junzhe
    Cui, Nan
    Li, Zhao
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (04): : 383 - 389
  • [24] Yoga for Gynaecological Cancer Patients: A Randomised Controlled Trial
    Archer, S.
    Sowter, H.
    Montague, J.
    Bali, A.
    PSYCHO-ONCOLOGY, 2013, 22 : 27 - 28
  • [25] Cardiac and pulmonary benefits of forest walking versus city walking in elderly women: A randomised, controlled, open-label trial
    Lee, Jee-Yon
    Lee, Duk-Chul
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2014, 6 (01) : 5 - 11
  • [26] Effects of laughter therapy on quality of life in patients with cancer: An open-label, randomized controlled trial
    Morishima, Toshitaka
    Miyashiro, Isao
    Inoue, Norimitsu
    Kitasaka, Mitsuko
    Akazawa, Takashi
    Higeno, Akemi
    Idota, Atsushi
    Sato, Akira
    Ohira, Tetsuya
    Sakon, Masato
    Matsuura, Nariaki
    PLOS ONE, 2019, 14 (06):
  • [27] Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
    Louis, Edouard
    Resche-Rigon, Matthieu
    Laharie, David
    Satsangi, Jack
    Ding, Nik
    Siegmund, Britta
    D'Haens, Geert
    Picon, Laurence
    Bossuyt, Peter
    Vuitton, Lucine
    Irving, Peter
    Viennot, Stephanie
    Lamb, Christopher A.
    Pollok, Richard
    Baert, Filip
    Nachury, Maria
    Fumery, Mathurin
    Gilletta, Cyrielle
    Almer, Sven
    Ben-Horin, Shomron
    Bouhnik, Yoram
    Colombel, Jean-Frederic
    Hertervig, Erik
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 215 - 227
  • [28] Withdrawal of Infliximab or Concomitant Immunosuppressant Therapy in Patients With Crohn's Disease on Combination Therapy (SPARE): A Multicentre, Open-Label, Randomised Controlled Trial
    Louis, E.
    Resche-Rigon, M.
    Laharie, D.
    DISEASES OF THE COLON & RECTUM, 2023, 66 (11) : 1520 - 1521
  • [29] Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial
    Dhar, Minakshi
    Mittal, Kartik
    Parchani, Ashwin
    Sharma, Manu
    Bahurupi, Yogesh
    Kalra, Sanjay
    Bhat, Nowneet Kumar
    BMJ OPEN, 2022, 12 (05):
  • [30] Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial
    Wang, Min
    Li, Dewei
    Chen, Rufu
    Huang, Xiaobing
    Li, Jing
    Liu, Yahui
    Liu, Jianhua
    Cheng, Wei
    Chen, Xuemin
    Zhao, Wenxing
    Li, Jingdong
    Tan, Zhijian
    Huang, Heguang
    Li, Deyu
    Zhu, Feng
    Qin, Tingting
    Ma, Jingdong
    Yu, Guangsheng
    Zhou, Baoyong
    Zheng, Shangyou
    Tang, Yichen
    Han, Wei
    Meng, Lingyu
    Ke, Jianji
    Feng, Feng
    Chen, Botao
    Yin, Xinmin
    Chen, Weibo
    Ma, Hongqin
    Xu, Jian
    Liu, Yifeng
    Lin, Ronggui
    Dong, Yadong
    Yu, Yahong
    Liu, Jun
    Zhang, Hang
    Qin, Renyi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (06): : 438 - 447